Zoekresultaten - 14 results
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
Burden and Impact Studies (VEBIS) project. A retrospective cohort was constructed from linked electronic health records (EHR) in each country. Countryspecific (level) relative VE (rVE) was estimated on ...
Vaccine effectiveness of the second and third COVID-19 boosters in Belgium (administered during 2022 autumn campaign)
following the autumn vaccination campaign of 2022, compared to those who did not receive a vaccine during this time. Health Topics: Vaccin Vaccin Vaccin Service: Épidémiologie des maladies infectieuses ...
Vaccinatiegraad en epidemiologische impact van de COVID-19-vaccinatiecampagne bij personen met onderliggende gezondheidsaandoeningen in België
.be/sites/default/files/Covid19/COVID-19_THEMATIC_REPORT_Vaccinatie%20van%20personen%20met%20onderliggende%20aandoeningen_NL.pdf Keywords: COVID-19 vaccination Underlying health conditions Abstract: Personen met bepaalde ...
Couverture vaccinale et impact épidémiologique de la campagne de vaccination COVID-19 chez les personnes présentant des maladies sous-jacentes en Belgique
.be/sites/default/files/Covid19/COVID-19_THEMATIC_REPORT_Vaccination%20des%20personnes%20pr%C3%A9sentant%20des%20maladies%20sous-jacentes%20_FR.pdf Keywords: COVID-19 vaccination Underlying health conditions Abstract: Certaines ...
Evaluation of quality and non-clinical data for licencing of vaccines
vaccines WHO Health Topics: Vaccin Vaccin Vaccin Efficacité et sécurité des vaccins, médicaments et produits de santé- Qualité des laboratoires médicaux Doeltreffendheid en veiligheid van vaccins, ...
Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation.
at batch release Belgian Change Clinical clinical trial Clinical trials Combination Components Control developing Development distribution EU European future Group Guidelines health Hepatitis Hepatitis ...
Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.
mediating protection. Health Topics: Vaccin Vaccin Service: Réponse immunitaire Immuunrespons Immune response Manuscript versions: DOI: https://doi.org/10.1128/IAI.69.5.3041-3047.2001 File: Version: Published Full ...
Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment.
mice. These results indicate that i.m. DNA vaccination is the method of choice for the induction of protective Th1 type immune responses with the Ag85A tuberculosis DNA vaccine. Health Topics: Vaccin ...
Cloning of the gene encoding a 22-kilodalton cell surface antigen of Mycobacterium bovis BCG and analysis of its potential for DNA vaccination against tuberculosis.
the 22-kDa antigen seems to have little potential for a DNA vaccine against tuberculosis, but it may be a good candidate for a mycobacterial antigen detection test. Health Topics: Vaccin Vaccin ...
Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A.
differing potencies, as the more immunogenic DNA construct encoding a secreted form of Ag85A was protective, whereas the less immunogenic DNA construct encoding a non-secreted form of Ag85A was not. Health ...